Alpha DNA Investment Management’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-10
Closed -$1K 630
2021
Q1
$1K Sell
10
-36
-78% -$4.48K ﹤0.01% 657
2020
Q4
$5K Buy
+46
New +$4.64K 0.01% 380

Other funds holding USPH

Alpha DNA Investment Management's USPH Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of US Physical Therapy (USPH) in Q2 2021, closing a stake of 10 shares — an estimated $1K sold.

Alpha DNA Investment Management first reported a position in USPH in Q4 2020 and held it in 2 quarters. The position peaked at $5K in Q4 2020. 219 funds tracked by Wall St. Rank hold USPH as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining US Physical Therapy position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 10 US Physical Therapy shares in Q2 2021, an estimated $1K.
  • Alpha DNA Investment Management first reported a position in US Physical Therapy in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's US Physical Therapy position peaked at $5K in Q4 2020.
  • 219 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.